AYM Syntex Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 6:36 pm

Competitors of AYM Syntex Ltd

All Competitor Stocks of AYM Syntex Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:45 pm

Below is a detailed analysis of the quarterly data for AYM Syntex Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 326.48 Cr.. The value appears to be declining and may need further review. It has decreased from 360.62 Cr. (Mar 2025) to 326.48 Cr., marking a decrease of 34.14 Cr..
• For Expenses, as of Jun 2025, the value is 309.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 333.91 Cr. (Mar 2025) to 309.80 Cr., marking a decrease of 24.11 Cr..
• For Operating Profit, as of Jun 2025, the value is 16.68 Cr.. The value appears to be declining and may need further review. It has decreased from 26.71 Cr. (Mar 2025) to 16.68 Cr., marking a decrease of 10.03 Cr..
• For OPM %, as of Jun 2025, the value is 5.11%. The value appears to be declining and may need further review. It has decreased from 7.41% (Mar 2025) to 5.11%, marking a decrease of 2.30%.
• For Other Income, as of Jun 2025, the value is 2.10 Cr.. The value appears to be declining and may need further review. It has decreased from 2.30 Cr. (Mar 2025) to 2.10 Cr., marking a decrease of 0.20 Cr..
• For Interest, as of Jun 2025, the value is 7.59 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.56 Cr. (Mar 2025) to 7.59 Cr., marking a decrease of 0.97 Cr..
• For Depreciation, as of Jun 2025, the value is 16.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.88 Cr. (Mar 2025) to 16.74 Cr., marking an increase of 0.86 Cr..
• For Profit before tax, as of Jun 2025, the value is -5.55 Cr.. The value appears to be declining and may need further review. It has decreased from 4.57 Cr. (Mar 2025) to -5.55 Cr., marking a decrease of 10.12 Cr..
• For Tax %, as of Jun 2025, the value is -36.04%. The value appears to be improving (decreasing) as expected. It has decreased from 55.58% (Mar 2025) to -36.04%, marking a decrease of 91.62%.
• For Net Profit, as of Jun 2025, the value is -3.55 Cr.. The value appears to be declining and may need further review. It has decreased from 2.03 Cr. (Mar 2025) to -3.55 Cr., marking a decrease of 5.58 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.61. The value appears to be declining and may need further review. It has decreased from 0.35 (Mar 2025) to -0.61, marking a decrease of 0.96.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:42 am

Growth

Last Updated: September 5, 2025, 12:15 am

Balance Sheet

Last Updated: November 9, 2025, 1:42 pm

Below is a detailed analysis of the balance sheet data for AYM Syntex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Sep 2025, the value is 516.00 Cr.. The value appears to be declining and may need further review. It has decreased from 519.00 Cr. (Mar 2025) to 516.00 Cr., marking a decrease of 3.00 Cr..
• For Borrowings, as of Sep 2025, the value is 238.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 202.00 Cr. (Mar 2025) to 238.00 Cr., marking an increase of 36.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 264.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 251.00 Cr. (Mar 2025) to 264.00 Cr., marking an increase of 13.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,077.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,031.00 Cr. (Mar 2025) to 1,077.00 Cr., marking an increase of 46.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 479.00 Cr.. The value appears to be declining and may need further review. It has decreased from 482.00 Cr. (Mar 2025) to 479.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Sep 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 61.00 Cr., marking an increase of 50.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 537.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 537.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,077.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,031.00 Cr. (Mar 2025) to 1,077.00 Cr., marking an increase of 46.00 Cr..

Notably, the Reserves (516.00 Cr.) exceed the Borrowings (238.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for AYM Syntex Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.13. This value is below the healthy minimum of 5. It has increased from 0.40 (Mar 24) to 2.13, marking an increase of 1.73.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.12. This value is below the healthy minimum of 5. It has increased from 0.40 (Mar 24) to 2.12, marking an increase of 1.72.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.59. This value is within the healthy range. It has increased from 11.84 (Mar 24) to 12.59, marking an increase of 0.75.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.74. It has increased from 83.71 (Mar 24) to 98.74, marking an increase of 15.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.74. It has increased from 83.71 (Mar 24) to 98.74, marking an increase of 15.03.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 254.53. It has decreased from 268.25 (Mar 24) to 254.53, marking a decrease of 13.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 21.22. This value is within the healthy range. It has decreased from 21.31 (Mar 24) to 21.22, marking a decrease of 0.09.
• For PBIT / Share (Rs.), as of Mar 25, the value is 10.62. This value is within the healthy range. It has increased from 9.87 (Mar 24) to 10.62, marking an increase of 0.75.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.26 (Mar 24) to 3.31, marking an increase of 3.05.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.99. This value is below the healthy minimum of 2. It has increased from 0.40 (Mar 24) to 1.99, marking an increase of 1.59.
• For PBDIT Margin (%), as of Mar 25, the value is 8.33. This value is below the healthy minimum of 10. It has increased from 7.94 (Mar 24) to 8.33, marking an increase of 0.39.
• For PBIT Margin (%), as of Mar 25, the value is 4.17. This value is below the healthy minimum of 10. It has increased from 3.67 (Mar 24) to 4.17, marking an increase of 0.50.
• For PBT Margin (%), as of Mar 25, the value is 1.30. This value is below the healthy minimum of 10. It has increased from 0.09 (Mar 24) to 1.30, marking an increase of 1.21.
• For Net Profit Margin (%), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 24) to 0.78, marking an increase of 0.63.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 15. It has increased from 0.48 (Mar 24) to 2.01, marking an increase of 1.53.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 8.93 (Mar 24) to 9.65, marking an increase of 0.72.
• For Return On Assets (%), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 5. It has increased from 0.19 (Mar 24) to 1.12, marking an increase of 0.93.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.08, marking a decrease of 0.19.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has decreased from 0.72 (Mar 24) to 0.32, marking a decrease of 0.40.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.45. It has increased from 1.40 (Mar 24) to 1.45, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.30. This value is below the healthy minimum of 1.5. It has increased from 1.05 (Mar 24) to 1.30, marking an increase of 0.25.
• For Quick Ratio (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.64, marking an increase of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.54. This value is below the healthy minimum of 4. It has decreased from 3.61 (Mar 24) to 3.54, marking a decrease of 0.07.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 3. It has increased from 2.57 (Mar 24) to 2.90, marking an increase of 0.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 3. It has increased from 1.21 (Mar 24) to 1.27, marking an increase of 0.06.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,441.00. It has increased from 721.89 (Mar 24) to 1,441.00, marking an increase of 719.11.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 24) to 0.96, marking an increase of 0.43.
• For EV / EBITDA (X), as of Mar 25, the value is 11.61. This value is within the healthy range. It has increased from 6.69 (Mar 24) to 11.61, marking an increase of 4.92.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.86, marking an increase of 0.54.
• For Price / BV (X), as of Mar 25, the value is 2.23. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 2.23, marking an increase of 1.20.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.86, marking an increase of 0.54.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness